CAPR News and Press, Capricor Therapeutics Inc. From 05/26/20

LOS ANGELES, May 26, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment and prevention of diseases, announced today that C...

Gainers: Renren (NYSE: RENN ) +66% . More news on: Renren Inc., SemiLEDs Corporation, Cheetah Mobile Inc., Stocks on the move, , Read more ...

Capricor Therapeutics Inc. (CAPR) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Corporate Participants AJ Bergmann - CFO Linda Marban - CEO Conference Call Participants Emanuela Branchetti - H.C. Wainwright Alan Leong - BioWatch Presentation Operator Gr...

The following slide deck was published by Capricor Therapeutics, Inc. in conjunction with their 2020 Q1 earnings Read more ...

Capricor Therapeutics (NASDAQ: CAPR ): Q1 GAAP EPS of -$0.30 beats by $0.07 . Revenue of $0.19M (-17.4% Y/Y) misses by $0.02M . Cash and equivalents of $13.2M. Press Release More news on: Capricor Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,

Duchenne Muscular Dystrophy Program -Final Top-Line 12-month Results from Phase II Randomized, Double-blind, Placebo-controlled HOPE-2- Study Demonstrated Improved Performance of Upper Limb (PUL) 2.0 (p=0.05)- COVID-19 Program -COVID-19 Compassionate Use Case Series Publis...

LOS ANGELES, May 13, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment and prevention of diseases, today announced that i...

Penny Stocks To Watch In The Middle Of The Month Are you looking for some penny stocks to buy ? If you said yes, you’re not alone. This year we’ve seen so much attention on trading penny stocks and for good reason. If you look back at years-past, these small-cap stocks have go...

Atomera (NASDAQ: ATOM )  -14%  on launch of stock offering. More news on: Atomera Incorporated, Infinera Corporation, Veeco Instruments Inc., Stocks on the move, , Read more ...

Capricor Therapeutics (NASDAQ: CAPR ) announces topline results from a Phase 2 clinical trial, HOPE-2 , evaluating lead candidate CAP-1002 in patients with advanced Duchenne muscular dystrophy (DMD). More news on: Capricor Therapeutics, Inc., Healthcare stocks news, Stocks on the move, ...